In patients with an ALT level > 2 ULN, the AFP/(ALT × AST) ratio (AUC 0.769; 95% CI 0.700-0.829) was better than the AFP tumor (P < 0.001) marker in diagnosing HCC, with its sensitivity and specificity significantly increasing. The gene discussed is AFP; the disease is hepatocellular carcinoma.